Early Life Intervention in Pediatrics Supported by E-health
Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Jan 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Early Life Intervention in Pediatrics Supported by E-health" is focused on addressing childhood obesity, which can lead to serious health issues later in life. The study aims to see if an eHealth application designed for parents can help reduce the amount of food their children eat and increase their physical activity. This trial is particularly looking for children who have a body mass index (BMI) above the 97th percentile, meaning they are considered very overweight for their age and sex.
To participate, parents need to speak German and have children who live with them and are attending a weight management clinic in Bern. The children should also meet the BMI requirement. Throughout the trial, families will be supported in making healthier lifestyle choices, which can include changes in diet and activity levels. It's important to note that children with certain medical conditions or who are involved in other similar studies are not eligible to join. This trial is currently recruiting participants, and it offers a chance for families to receive guidance and support in managing their children's weight in a healthy way.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • German speaking parents
- • Any ethnic background/race
- • Children should live/grow-up in the same household as the parental participant
- • Children with an age- and sex-matched BMI \>97 centile according to Swiss national growth charts
- • Children who newly attend the outpatient weight management clinic at the Division of Pediatric Endocrinology at the University Children's Hospital Bern
- • Signed informed consent form from parent(s)
- Exclusion Criteria:
- • Syndromic obesity
- • Known congenital disease affecting musculo-skeletal, cardiac or pulmonary function
- • Insufficient knowledge of German language
- • Participation in another clinical trial targeting similar objectives
About Insel Gruppe Ag, University Hospital Bern
Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, , Switzerland
Patients applied
Trial Officials
Matthias V. Kopp, Prof. Dr.
Principal Investigator
Department of Paediatrics, Inselspital, Bern University Hospital, University of Bern, Switzerland
Michael Kaess, Prof. Dr.
Principal Investigator
Universitäre Psychiatrische Dienste Bern (UPD), University of Bern, Switzerland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported